A survey of current practices used to maintain surgically induced remission following intestinal resection for Crohn’s disease
- 9 March 2013
- journal article
- research article
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 28 (8) , 1073-1079
Abstract
Background and aims Post-operative Crohn’s disease (CD) recurrence is common after intestinal resection. The European Crohn’s and Colitis Organization has issued guidelines regarding the optimal post-operative management of patients who have undergone intestinal resection for CD. The current study aims to assess the current adjuvant therapy practices of colorectal surgeons and gastroenterologists. Methods An electronic-based survey was sent to members of the Association of Coloproctology of Great Britain and Ireland and the Irish Society of Gastroenterology. Results One hundred twenty-five surgeons and gastroenterologists responded. Gastroenterologists more frequently assessed for pre-clinical recurrence with serum inflammatory markers (97 vs. 51 %, P < 0.001), faecal calprotectin (30 vs. 10 %, P = 0.008) and ileocolonoscopy (67 vs. 23 %, P < 0.001), while surgeons more frequently performed a CT scan (23 vs. 6 %, P = 0.037). The majority of respondents estimated the 1-year endoscopic recurrence to be 10–25 %, and 36 % of respondents offered prophylaxis to all post-operative patients. Budesonide (8 vs. 4 %, P = 0.006) and azathioprine/mercaptopurine (60 vs. 33 %, P < 0.001) were more often prescribed for high-risk patients, while imidazole antibiotics (11 vs. 5 %, P < 0.001) and 5-ASA derivatives were more often prescribed for low-risk patients (51 vs. 14 %, P < 0.001). Conclusion Currently, surgeons and gastroenterologists involved in the peri-operative care of patients with CD underestimate the risk of recurrence following intestinal resection and under-utilize ileocolonoscopy to tailor adjuvant therapy.Keywords
This publication has 32 references indexed in Scilit:
- Validating Crohnʼs disease activity indices for use in assessing postoperative recurrenceInflammatory Bowel Diseases, 2011
- Postoperative Infliximab Is Not Associated with An Increase in Adverse Events in Crohn’s DiseaseDigestive Diseases and Sciences, 2011
- Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's diseaseCochrane Database of Systematic Reviews, 2011
- Meta‐analysis: targeting the intestinal microbiota in prophylaxis for post‐operative Crohn’s diseaseAlimentary Pharmacology & Therapeutics, 2010
- Severity of postoperative recurrence in crohnʼs disease: Correlation between endoscopic and sonographic findingsInflammatory Bowel Diseases, 2009
- Interventions for prevention of post-operative recurrence of Crohn's diseaseCochrane Database of Systematic Reviews, 2009
- Meta-Analysis of the Placebo Rates of Clinical Relapse and Severe Endoscopic Recurrence in Postoperative Crohn's DiseaseGastroenterology, 2008
- The impact of the Calman–Hine report on the processes and outcomes of care for Yorkshire's colorectal cancer patientsBritish Journal of Cancer, 2006
- Recurrence rates in Crohn’s disease: predicting the future and predicting the pastGut, 2006
- Risk Factors for Surgery and Postoperative Recurrence in Crohn’s DiseaseAnnals of Surgery, 2000